A study to investigate different doses of 0382 in overweight and obese subjects with type 2 diabetes mellitus.

Trial Identifier: D5670C00011
Sponsor: MedImmune, LLC
NCTID:: NCT03244800
Start Date: September 2017
Primary Completion Date: January 2018
Study Completion Date: January 2018
Condition: Diabetes: Type 2

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Translation
German Translation

Trial Locations

Country Location
Germany Berlin, Germany, 10117
Germany Magdeburg, Germany, 39120
Germany Mainz, Germany, 55116
Germany Neuss, Germany, 41460
Germany Neu-Ulm, Germany, 89231